Logo image
Prosthetic Joint Infection Risk After Total Hip Arthroplasty in the Medicare Population
Journal article   Peer reviewed

Prosthetic Joint Infection Risk After Total Hip Arthroplasty in the Medicare Population

Kevin L. Ong, Steven M. Kurtz, Edmund Lau, Kevin J. Bozic, Daniel J. Berry and Javad Parvizi
The Journal of arthroplasty, v 24(6)
2009
PMID: 19493644

Abstract

epidemiology infection Medicare total hip arthroplasty
Periprosthetic joint infection is one of the most challenging complications of total joint arthroplasty. We evaluated the incidence of early-onset (less than 2 years) and late-onset (greater than 2 years) periprosthetic joint infection after primary total hip arthroplasty (THA). The Medicare 5% national sample data set (1997-2006) was used to longitudinally follow primary THA patients. Deep infections were identified with the International Classification of Diseases, Ninth Revision, Clinical Modification code 996.66. Kaplan-Meier survivorship curves were compiled with infection as the end point. Cox regression was used to evaluate patient and hospital characteristics. Eight hundred eighty-seven THA infections were identified from 39 929 THA patients. The incidence of infection was 1.63% within 2 years and 0.59% between 2 and 10 years. Comorbidities, sex, procedure duration, and socioeconomic status were found to be significant risk factors. This is the first study to establish the incidence and risk factors associated with early onset and delayed periprosthetic joint infection in the Medicare patient population.

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Orthopedics
Logo image